Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Zhengye ZYBT Trading Strategy Zhengye Biotechnology posts 024 EPS 186M revenue no estimates Prestige PBH Stock Resistance Levels Underperforming 20260416 GLDD Great Lakes Dredge and Dock Corporation posts robust Q4 2025 results as earnings per share far outpace analyst forecasts TMobile US Inc TMUS Valuation Assessment Amid Mixed NearTerm Share Price Performance CF Financial CFFI Stock PostEarnings Weakens 20260420 Why Tyra Biosciences TYRA earnings beat or miss matters less than you think Tyra Biosciences Misses EPS Estimates by 58 SOHOO Sotherly posts Q2 2025 preferred stock EPS of 21 cents shares stay flat in regular trading today Trump Tells Xi He Doesnt Talk About Taiwan Defense Policy Amid Trade Iran Talks New Report Highlights AIs Expanding Role in Business Growth HS2 Failures Blamed on HighSpeed Obsession and Political Interference Review Finds Life Time LTH Delivers Q1 2026 Beat EPS 039 vs 035 Expected SL Green SLG Q1 2026 Earnings Miss EPS 120 vs 072 Expected DBA SBSW Stock Consolidating at 1210 Next Move Ahead 20260518 Trumps Stock Moves Intel Deal Grabs Headlines Nvidia Purchase in Q1 Draws Investor Attention Oil Markets Wary as Potential Strait of Hormuz Fees Loom Data Chiefs Signal Investor Caution AIPowered Job Applications Flood Market Raising Concerns Over Homogeneous Candidate Profiles Signos Raises 20 Million and Expands Dexcom Partnership to Capitalize on GLP1 Weight Loss Trend with AI Health Tracking Kalshi Launches Prediction Markets for Art Auction Outcomes Avoiding the Pitfalls of Chasing Returns in Financial Markets Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development CWCO Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment MCRB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues RD Focus IRIX Q1 2026 Earnings NarrowerThanExpected Loss Marks Positive Surprise GPOR Q1 2026 Earnings EPS Slightly Misses Consensus Shares Edge Lower National CineMedia NCMI Holds Steady Near 299 as Indecision Lingers Mach Natural Resources MNR Faces Headwinds Down 249 as Support Levels Tested Graham Holdings GHC Holds Steady Near Support After Modest Gains Fortress Biotech Preferred FBIOP Rises 237 Support and Resistance in Focus Immunovant IMVT Edges Lower Amid Consolidation Support and Resistance Levels in Focus